Dr. Weibo Luo is currently an Associate Professor of Pathology and Paharmacology. Dr. Luo received his Ph.D summa cum laude from the University of Magdeburg in Germany and completed his postdoctoral fellowship and instructorship at the Johns Hopkins University School of Medicine before joining UT Southwestern.

Dr. Luo studies epigenetic and metabolic alterations through crosstalk with hypoxia in cancer development with the goal of identifiying vulnerability to treat human cancers.

Research Interest

  • Drug resistance
  • Epigenetics
  • Hypoxia/Hypoxia-inducible factor
  • Immunotherapy
  • Metabolism
  • Tumor initiation, growth, and metastasis


Featured Publications LegendFeatured Publications

KDM6B promotes PARthanatos via suppression of O6-methylguanine DNA methyltransferase repair and sustained checkpoint response.
Yang M, Wang C, Zhou M, Bao L, Wang Y, Kumar A, Xing C, Luo W, Wang Y, Nucleic Acids Res 2022 Jun 50 11 6313-6331

Honors & Awards

  • ACS Research Scholar
  • Mary Kay Foundation Research Award
  • Susan G. Komen Career Catalyst Research Award
  • Welch Foundation Research Award
  • American Cancer Society (ACS-IRG) New Investigator Awards in Cancer Research
  • CPRIT Scholar in Cancer Research
    Cancer Prevention Research Institute of Texas (2014)
  • AACR-Bristol-Myers Squibb Oncology Scholar-in-Training Award
    American Association for Cancer Research (2013)
  • NIH Pathway to Independence Award
    National Cancer Institute (2013)
  • Albert L. Lehninger Postdoctoral Research Award
    The Johns Hopkins University School of Medicine (2012)
  • FARMS Postdoctoral Fellowship
    Dr. Richard and Mavis Fowler Foundation for Advanced Research in the Medical Sciences, Inc (2011)
  • PhD summa cum laude
    University of Magdeburg, Germany (2007)

Professional Associations/Affiliations

  • American Association for Cancer Research (2011)